Walgreens Boots (NASDAQ:WBA) pared a bit of its decline amid a report that private equity firm Sycamore Partners is talking ...

Walgreens improving pharmacy business and comments from the company’s CEO are convincing Wall Street that the drugstore won't ...

Walgreens Boots (NASDAQ:WBA) fell 6.6% on a report that a potential takeover by private equity from Sycamore Partners is likely not going to happen. "It's mostly dead," CNBC's David Faber said on ...

Walgreens Boots Alliance Inc.’s chairman and biggest shareholder, Stefano Pessina, has dealmaking in his DNA. Yet finding a ...

A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York ...

Shares of Walgreens Boots Alliance tumbled today following a CNBC report that the Deerfield-based pharmacy chain was unlikely to sell itself to a private-equity firm. CNBC’s David Faber reported on ...

The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be finalized early this year.

Many finance professionals -- and not a few investors -- consider Walgreens a juicy target for private equity players. In fact, according to reporting from Bloomberg and The Financial Times in 2019, ...

Private equity firm Sycamore Partners has been speaking with private credit firms about debt financing for a potential Walgreens deal, according to people familiar with the matter, despite an ...

Shares of Walgreens Boots Alliance (WBA) are down about 3% to $11.49 in early trading after CNBC’s David Faber said on-air that his sources ...

NEW YORK: Sycamore Partners said it would acquire US office supplies chain Staples Inc for US$6.9bil, a rare bet by a private equity firm this year in the US retail sector, which has been roiled ...

Check out who's buying and selling in this week's roundup of healthcare mergers, acquisitions and joint ventures.